
1	JAGX	Jaguar Health, Inc.	$0.1375	-46.81%	35.6M	Jaguar Health, Inc.2 days ago JAGUAR HEALTH, INC. ANNOUNCES REVERSE STOCK SPLIT News reverse split approved at april 2024 special meeting of stockholders shares of jaguar health common stock to begin trading on split-adjusted basis on may 23, 2024 san francisco, ca / accesswire / may 17, 2024 / jaguar health, inc. (nasdaq:jagx) ("jaguar" or the "company") today announced that the company will effect a reverse stock split of its issued and outstanding voting common stock ("common stock"), at an exchange ratio of 1-for-60, on thursday, may 23, 2024 (the "effective date") in order to support the company's compliance with nasdaq's listing standards. the company's common stock will begin trading on a split-adjusted basis when the market opens on the effective date and will remain listed on the nasdaq capital market under the symbol "jagx". News 2 days ago	Buy
2	VIRI	Virios Therapeutics, Inc.	$0.2328	-33.75%	731,113	N/A	N/A
3	AKAN	Akanda Corp.	$0.1149	-33.43%	28.1M	N/A	N/A
4	JFBR	Jeffs' Brands Ltd	$0.47	-27.47%	1.41M	N/A	N/A
5	SLNA	Selina Hospitality PLC	$0.0909	-17.36%	9.36M	N/A	N/A
6	CETX	Cemtrex Inc.	$0.411	-15.61%	2.04M	N/A	Buy
7	CRKN	Crown Electrokinetics Corp.	$0.14495	-15.23%	101M	N/A	N/A
8	LSDI	Lucy Scientific Discovery Inc.	$1.26	-13.70%	72,872	N/A	N/A
9	GWAV	Greenwave Technology Solutions, Inc.	$0.133	-13.69%	38.7M	Greenwave Technology Solutions, Inc.10 days ago GREENWAVE TECHNOLOGY SOLUTIONS EXPECTS TO PROCESS RECORD VOLUMES OF STEEL AND COPPER WITH REVENUES EXCEEDING $40 MILLION IN 2024 News growth being driven by cleveland, oh and virginia beach, va locations cashflows and ebitda to be accelerated once its second american pulverizer 60x85 shredder commencing operations chesapeake, va. , may 9, 2024 /prnewswire/ -- greenwave technology solutions, inc. ("greenwave" or the "company") (nasdaq: gwav), a leading operator of metal recycling facilities in virginia, north carolina, and ohio, is pleased to report that it is expecting to generate revenues exceeding $40 million during the year ended december 31, 2024. News 10 days ago	N/A
10	BNRG	Brenmiller Energy Ltd	$1.7514	-12.87%	92,943	N/A	N/A
11	BSFC	Blue Star Foods Corp.	$0.06675	-11.94%	3.99M	N/A	Sell
12	ASTI	Ascent Solar Technologies, Inc	$0.1111	-10.55%	2.32M	N/A	N/A
13	SILO	Silo Pharma, Inc.	$1.802	-10.35%	400	N/A	N/A
14	PEGY	Pineapple Energy Inc.	$0.0948	-10.06%	4.98M	N/A	N/A
15	KAVL	Kaival Brands Innovations Group, Inc.	$2.8093	-9.96%	979	N/A	N/A
16	WLGS	Wang & Lee Group, Inc.	$0.5951	-9.83%	17,860	N/A	N/A
17	LIXT	Lixte Biotechnology Holdings, Inc.	$2.23	-9.36%	3,120	N/A	N/A
18	BKYI	BIO-key International, Inc.	$1.55	-9.36%	1,556	N/A	N/A
19	CYN	Cyngn Inc.	$0.106	-9.25%	6.84M	Cyngn Inc.3 days ago CYNGN SCALES UP COMMERCIALIZATION OF AUTONOMOUS VEHICLE SOLUTIONS IN FIRST QUARTER 2024 News joined john deere supply base and chosen to deploy drivemod tuggers to dubuque, ia operation. renewed contract with us continental , unveiling a study that found cyngn's autonomous vehicles yielded 4x efficiency gain. News 3 days ago	N/A
20	BRSH	Bruush Oral Care Inc.	$0.107	-8.70%	2.08M	Bruush Oral Care Inc.1 month ago BRÜUSH RECEIVES ADDITIONAL DELISTING NOTIFICATION TO ADDRESS AT HEARING News vancouver, bc / accesswire / april 19, 2024 / bruush oral care inc. (nasdaq:brsh) (the "company"), today announced that it received a notice (the "notice") from the listing qualifications department of the nasdaq stock market, llc ("nasdaq") on april 15, 2024 notifying the company that because it is not compliant with nasdaq's audit committee requirements as set forth in listing rule 5605 (the "audit committee requirements"), this deficiency serves as an additional basis for delisting the company's securities from nasdaq. this deficiency will be considered by the hearings panel (the "panel") at a hearing that has been scheduled for april 25, 2024 (the "hearing") to address the company's other current deficiencies. News 1 month ago	N/A
21	SIEB	Siebert Financial Corp.	$2.1	-8.70%	5,000	N/A	N/A
22	KITT	Nauticus Robotics, Inc.	$0.173	-8.56%	240,066	Nauticus Robotics, Inc.6 days ago NAUTICUS ROBOTICS ANNOUNCES RESULTS FOR THE FIRST QUARTER OF 2024 News houston , may 13, 2024 /prnewswire/ -- nauticus robotics, inc. ("nauticus" or the "company") (nasdaq: kitt) today announced its financial results for the quarter ended march 31, 2024. "we have successfully deployed aquanaut mark 2 in the gulf of mexico and tested the platform at depths greater than 1300 meters," said john w. News 6 days ago	Hold
23	KXIN	Kaixin Holdings	$0.1949	-8.50%	400,303	N/A	N/A
24	REVB	Revelation Biosciences, Inc.	$1.85	-8.42%	320	N/A	Buy
25	ZKIN	ZK International Group Co., Ltd	$0.6872	-8.36%	100	N/A	N/A
26	KOSS	Koss Corporation	$4.41	-7.93%	30,137	N/A	N/A
27	HEPA	Hepion Pharmaceuticals, Inc.	$1.2	-7.69%	774	Hepion Pharmaceuticals, Inc.1 month ago HEPION PHARMACEUTICALS INITIATES WIND-DOWN ACTIVITIES IN PHASE 2B ‘ASCEND-NASH' TRIAL News edison, n.j., april 19, 2024 (globe newswire) -- hepion pharmaceuticals, inc. (nasdaq:hepa), a clinical stage biopharmaceutical company that has been developing a treatment for non-alcoholic steatohepatitis (“nash”), hepatocellular carcinoma (“hcc”), and other chronic liver diseases, today announced that it has begun wind-down activities in its ascend-nash trial, while continuing to explore strategic alternatives, as previously announced in december 2023. News 1 month ago	Buy
28	VHAI	Vocodia Holdings Corp.	$0.18	0	4.51M	N/A	N/A
29	MSCI	MSCI Inc.	$505.33	0	95,848	MSCI Inc.2 days ago MSCI PUBLISHED AN INVESTOR PRESENTATION News new york--(business wire)--msci inc. (“msci” or the “company”) (nyse: msci), a leading provider of critical decision support tools and services for the global investment community, published an investor presentation on its investor relations homepage, ir.msci.com, on friday, may 17, 2024. the company's management may use this presentation during meetings with investors and analysts. about msci inc. msci is a leading provider of critical decision support tools and services for the global investm. News 2 days ago	Buy
30	CTSO	Cytosorbents Corporation	$0.9004	-6.95%	38,254	Cytosorbents Corporation10 days ago CYTOSORBENTS REPORTS FIRST QUARTER 2024 RESULTS News product sales up a robust 14% over prior year, and a significant 22% sequentially we believe the star-t data presented at aats support a favorable benefit-to-risk profile of drugsorb-atr in coronary artery bypass graft (cabg) patients on track for u.s. food and drug administration (fda) de novo and health canada submissions for drugsorb®-atr in q3 2024 princeton, n.j., may 09, 2024 (globe newswire) -- cytosorbents corporation (nasdaq: ctso), a pioneer in critical care and cardiac surgery blood purification technologies, today reported unaudited financial and operating results for the quarter ended march 31, 2024. News 10 days ago	N/A
31	ENSC	Ensysce Biosciences, Inc.	$0.5812	-6.86%	605	N/A	Buy
32	IPA	ImmunoPrecise Antibodies Ltd.	$1.1	-6.78%	100	N/A	N/A
33	BNED	Barnes & Noble Education, Inc	$0.42	-6.67%	5.93M	Barnes & Noble Education, Inc4 days ago BARNES & NOBLE EDUCATION ANNOUNCES EFFECTIVENESS OF REGISTRATION STATEMENT RELATING TO $45 MILLION RIGHTS OFFERING FOR COMMON STOCK AND COMMENCEMENT OF RIGHTS OFFERING News basking ridge, n.j.--(business wire)--barnes & noble education, inc. (nyse: bned) (“bned” or the “company”), a leading solutions provider for the education industry, announced today that its registration statement for its fully backstopped $45 million equity rights offering (the “rights offering”), was declared effective by the securities and exchange commission (“sec”) on may 14, 2024. the rights offering is one of the previously announced proposed transactions (the “transactions”) contemp. News 4 days ago	Buy
34	AGRI	AgriFORCE Growing Systems Ltd.	$0.0965	-6.58%	1.64M	N/A	Buy
35	SVMH	SRIVARU Holding Limited	$0.1512	-2.45%	32,564	N/A	N/A
36	RDZN	Roadzen, Inc.	$3.2	-6.43%	3,435	Roadzen, Inc.20 days ago DALMIA TRANSPORT SELECTS ROADZEN'S DRIVEBUDDYAI TO ENHANCE FLEET SAFETY WITH ADVANCED COMPUTER VISION News new york, april 29, 2024 (globe newswire) -- roadzen inc. (nasdaq: rdzn) ("roadzen" or the "company"), a global leader in ai at the convergence of insurance and mobility, today announced that dalmia transport & logistics ("dalmia") has selected roadzen's proprietary adamatics technology platform, drivebuddyai, for its fleet operations. roadzen's strategic partnership with dalmia will span five years. the selection of roadzen's technology was finalized after a comprehensive three-month validation process of drivebuddyai by dalmia. News 20 days ago	N/A
37	LMFA	LM Funding America, Inc.	$2.8	-6.35%	148	N/A	N/A
38	RCRT	Recruiter.com Group, Inc.	$1.77	-6.35%	8,771	N/A	N/A
39	NAOV	NanoVibronix, Inc.	$0.71	-6.17%	1,000	N/A	N/A
40	ELUT	Elutia, Inc.	$3.11	-6.04%	1,289	N/A	N/A
41	CTNT	Cheetah Net Supply Chain Service Inc.	$10.16	-5.93%	66,130	N/A	N/A
42	JAN	JanOne Inc.	$3.19	-5.90%	10,332	N/A	N/A
43	SGE	Strong Global Entertainment, Inc.	$1.3	-5.80%	1,249	N/A	N/A
44	LUXH	LuxUrban Hotels Inc.	$0.47	-5.75%	20,979	N/A	N/A
45	SGD	Safe and Green Development Corporation	$0.4997	-5.72%	50,247	N/A	N/A
46	BHAT	Blue Hat Interactive Entertainment Technology	$1.05	-5.40%	6,400	Blue Hat Interactive Entertainment Technology5 days ago BLUE HAT INTERACTIVE ENTERTAINMENT TECHNOLOGY(NASDAQ: BHAT) ANNOUNCES ARTIFICIAL INTELLIGENCE "AILEEN" AS CHIEF INFORMATION OFFICER News hong kong , may 15, 2024 /prnewswire/ -- driven by artificial intelligence technology, blue hat interactive entertainment (ticker: bhat) today announced that an independently developed ai digital person, " aileen," will serve as the company's chief information officer (cio). the development of this ai digital person is based on the company's long-term technical buildup in the gaming field and in-depth application of market-leading third-party ai technology, marking an important step for bhat in the field of ai application services. News 5 days ago	N/A
47	FEAM	5E Advanced Materials, Inc.	$1.4201	-5.33%	11,100	N/A	Buy
48	MSGM	Motorsport Games Inc.	$2.68	-5.30%	2,417	N/A	N/A
49	RBOT	Vicarious Surgical Inc.	$0.4223	0	129,886	N/A	Buy
50	HUDI	Huadi International Group Co., Ltd.	$2.81	-5.07%	535	N/A	N/A
51	BMRA	Biomerica, Inc.	$0.632	-5.01%	3,126	N/A	N/A
52	CPOP	Pop Culture Group Co., Ltd	$1.71	-5.00%	2,774	Pop Culture Group Co., Ltd3 years ago POP CULTURE GROUP CO., LTD COMPLETES THE REGULAR SEASON OF 2021 CHINA BATTLE CHAMPIONSHIPS News xiamen, china, oct. 14, 2021 /prnewswire/ -- pop culture group co., ltd ("pop culture" or the "company") (nasdaq: cpop), a hip-pop culture company in china, announced today that the regular season of 2021 china battle championships ("cbc") was completed in early october. the preseason of 2021 cbc was completed in september. News 3 years ago	N/A
53	LUNG	Pulmonx Corporation	$8.55	-5.00%	47,927	Pulmonx Corporation3 days ago FDA APPROVES IMDELLTRA™ (TARLATAMAB-DLLE), THE FIRST AND ONLY T-CELL ENGAGER THERAPY FOR THE TREATMENT OF EXTENSIVE-STAGE SMALL CELL LUNG CANCER News breakthrough dll3-targeting therapy regimen for a major solid tumor imdelltra demonstrated impressive 40% objective response rate, 9.7 month median duration of response and 14.3 month median overall survival in pivotal dellphi-301 study amgen to host webcast investor call on may 20, 2024 at 1:00 p.m. pt thousand oaks, calif. News 3 days ago	Buy
54	COEP	Coeptis Therapeutics Holdings, Inc.	$0.3326	-5.00%	1,169	N/A	N/A
55	LBPH	Longboard Pharmaceuticals, Inc.	$19.66	-4.98%	43,476	N/A	Buy
56	YGMZ	MingZhu Logistics Holdings Limited	$0.3412	-4.96%	15,333	N/A	N/A
57	SERV	Serve Robotics Inc.	$3.08	-4.94%	3,616	N/A	N/A
58	LDWY	Lendway, Inc.	$5.415	0	600	N/A	N/A
59	BAER	Bridger Aerospace Group Holdings, Inc.	$3.95	-4.82%	1,572	N/A	N/A
60	OCG	Oriental Culture Holding LTD	$1.4	-4.76%	894	N/A	N/A
61	MRAI	Marpai, Inc.	$2	-4.76%	4,003	N/A	Buy
62	LEXX	Lexaria Bioscience Corp.	$3	-4.76%	7,433	N/A	N/A
63	MRSN	Mersana Therapeutics, Inc.	$2.6	-4.76%	332,949	N/A	Buy
64	ENVB	Enveric Biosciences, Inc.	$0.8	-4.76%	21,424	N/A	N/A
65	BACK	IMAC Holdings, Inc.	$3.4938	+3.37%	420	N/A	N/A
66	VS	Versus Systems Inc.	$1.41	-4.73%	2,001	N/A	N/A
67	GDHG	Golden Heaven Group Holdings Ltd.	$0.2764	-4.69%	280,191	N/A	N/A
68	PHIO	Phio Pharmaceuticals Corp.	$0.75	-4.69%	4,276	Phio Pharmaceuticals Corp.2 days ago PHIO PHARMACEUTICALS SECURES NEW INVESTOR News marlborough, mass., may 17, 2024 (globe newswire) -- phio pharmaceuticals corp. (nasdaq: phio), a clinical stage biotechnology company whose proprietary intasyl™ sirna gene silencing technology is designed to make immune cells more effective in killing tumor cells, today announced it has entered into a purchase agreement with triton funds. News 2 days ago	N/A
69	OMER	Omeros Corporation	$3.29	-4.64%	26,335	N/A	Hold
70	UCAR	U Power Limited	$6.37	0	1,565	N/A	N/A
71	RDVT	Red Violet, Inc.	$19.52	-4.55%	4,400	N/A	N/A
72	NITO	N2OFF, Inc.	$1.05	-4.55%	9,767	N/A	N/A
73	TELO	Telomir Pharmaceuticals, Inc.	$6.18	0	100	N/A	N/A
74	AKTS	Akoustis Technologies, Inc.	$0.3401	-4.52%	116,852	N/A	Buy
75	CLRO	ClearOne, Inc.	$0.86	-4.44%	27,349	N/A	N/A
76	COOT	Australian Oilseeds Holdings Limited	$1.08	-4.42%	510	N/A	N/A
77	LAES	SEALSQ Corp	$1.08	-4.37%	8,026	N/A	N/A
78	ECDA	ECD Automotive Design, Inc.	$1.1	-4.35%	775	N/A	N/A
79	TWG	Top Wealth Group Holding Limited	$1.11	-4.31%	3,160	N/A	N/A
80	RAY	Raytech Holding Limited	$4.01	-4.30%	4,059	Raytech Holding Limited2 days ago RAYTECH HOLDING LIMITED ANNOUNCES CLOSING OF $6 MILLION INITIAL PUBLIC OFFERING News hong kong, may 17, 2024 (globe newswire) -- raytech holding limited (the “company” or “ray”), a hong kong-headquartered company specializing in design, sourcing and wholesale of personal care electrical appliances for international brand owners, today announced the closing of its initial public offering (the "offering") of 1,500,000 ordinary shares (the "ordinary shares") at an initial public offering price of $4 per share for total gross proceeds of $6,000,000, before deducting underwriting discounts and other offering expenses. the offering closed on may 17, 2024, and the ordinary shares began trading on nasdaq capital market on may 15, 2024, under the ticker symbol "ray". the company has granted the underwriters, an option, within 45 days from the closing date of the offering, to purchase up to an additional 225,000 ordinary shares at the initial public offering price, less underwriting discounts, to cover the over-allotments, if any. News 2 days ago	N/A
81	KIND	Nextdoor Holdings, Inc.	$2.31	-4.15%	71,555	N/A	Hold
82	SCYX	SCYNEXIS, Inc.	$2.6559	-4.12%	5,761	SCYNEXIS, Inc.11 days ago SCYNEXIS REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE News jersey city, n.j., may 08, 2024 (globe newswire) -- scynexis, inc. (nasdaq: scyx), a biotechnology company pioneering innovative medicines to overcome and prevent difficult-to-treat and drug-resistant infections, today reported financial results for the first quarter ended march 31, 2024. News 11 days ago	Buy
83	GME	GameStop Corporation	$21.3	-4.10%	2.39M	N/A	Hold
84	JYD	Jayud Global Logistics Limited	$0.7	-4.11%	383,144	N/A	N/A
85	RELI	Reliance Global Group, Inc.	$0.3	-4.09%	64,700	N/A	N/A
86	SRM	SRM Entertainment, Inc.	$1.41	-4.08%	2,684	N/A	N/A
87	NAUT	Nautilus Biotechnology, Inc.	$2.83	-4.07%	12,368	Nautilus Biotechnology, Inc.19 days ago NAUTILUS BIOTECHNOLOGY REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS News seattle, april 30, 2024 (globe newswire) -- nautilus biotechnology, inc. (nasdaq: naut; or “nautilus”), a company pioneering a single molecule proteome analysis platform, today reported financial results for the first quarter ended march 31, 2024. News 19 days ago	Sell
88	IBIO	iBio, Inc.	$1.98	0	1,677	N/A	Hold
89	BIOR	Biora Therapeutics, Inc.	$0.7003	-4.03%	1,813	Biora Therapeutics, Inc.4 days ago BIORA THERAPEUTICS PROVIDES CORPORATE UPDATE AND REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS News dosing of all patients in clinical trial of bt-600 has been successfully completed, with results anticipated in late q2 2024 clinical data on device function of the navicap™ platform to be presented at ddw on may 19 partnering process for the biojet oral delivery platform is progressing well management will host conference call and webcast today at 4:30 pm eastern / 1:30 pm pacific san diego, may 15, 2024 (globe newswire) -- biora therapeutics, inc. (nasdaq: bior), the biotech company that is reimagining therapeutic delivery, today provided a corporate update and reported financial results for the first quarter ended march 31, 2024. “we were gratified to see the excellent interim results from our clinical trial for bt-600, where we observed a pharmacokinetic profile consistent with drug delivery and absorption in the colon,” said adi mohanty, chief executive officer of biora therapeutics. News 4 days ago	Buy
90	ITP	IT Tech Packaging, Inc.	$0.3012	-0.40%	1,733	N/A	Sell
91	ZCMD	Zhongchao Inc.	$1.49	-1.32%	2,200	N/A	N/A
92	GPAK	Gamer Pakistan Inc.	$0.2302	-3.96%	395	N/A	N/A
93	VVOS	Vivos Therapeutics, Inc.	$2.2	-3.93%	2,306	Vivos Therapeutics, Inc.5 days ago VIVOS THERAPEUTICS REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS AND PROVIDES OPERATIONAL UPDATE News vivos expanding its revenue generating initiatives as operating expenses decrease 22%, representing seven consecutive quarters of year over year improvement due to successful cost cutting initiatives News 5 days ago	N/A
94	GNPX	Genprex, Inc.	$2.45	-3.92%	2,300	Genprex, Inc.5 days ago GENPREX DOSES FIRST PATIENT IN ACCLAIM-3 CLINICAL STUDY OF REQORSA® IMMUNOGENE THERAPY IN COMBINATION WITH TECENTRIQ® TO TREAT SMALL CELL LUNG CANCER News expects to initiate the phase 2 expansion study in the second half of 2024 acclaim-3 study supported by fda orphan drug and fast track designations austin, texas , may 14, 2024 /prnewswire/ -- genprex, inc. ("genprex" or the "company") (nasdaq: gnpx), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced that the first patient has been enrolled and dosed in the company's phase 1 dose escalation portion of the acclaim-3 clinical study of reqorsa® (quaratusugene ozeplasmid) immunogene therapy in combination with genentech's tecentriq® to treat patients with extensive-stage small cell lung cancer (es-sclc). "we are excited to take this next step in our fight against lung cancers as we work to advance an innovative therapy that we believe provides hope to patients suffering with es-sclc, an especially aggressive form of lung cancer that has extremely limited treatment options," said ryan confer, president and chief executive officer at genprex. News 5 days ago	N/A
95	INO	Inovio Pharmaceuticals, Inc.	$11.5316	-3.90%	13,011	N/A	Buy
96	NBY	NovaBay Pharmaceuticals, Inc.	$0.1124	-5.23%	1.9M	N/A	Buy
97	ATNF	180 Life Sciences Corp.	$1.5201	-3.79%	500	180 Life Sciences Corp.2 months ago 180 LIFE SCIENCES REGAINS FULL COMPLIANCE WITH NASDAQ MINIMUM BID PRICE REQUIREMENT News palo alto, calif., march 14, 2024 (globe newswire) -- 180 life sciences corp. (nasdaq: atnf) (“180 life sciences” or the “company”), today announced that the company received a letter on march 13, 2024 from the nasdaq stock market llc (“nasdaq”) indicating that the company has regained full compliance with the minimum bid price for continued listing on the nasdaq pursuant to nasdaq listing rule 5550(a)(2) (“minimum bid price requirement”). News 2 months ago	N/A
98	NXU	Nxu, Inc.	$0.45	-3.76%	5,465	N/A	N/A
99	OCX	Oncocyte Corporation	$2.93	0	789	N/A	Buy
100	MCRB	Seres Therapeutics, Inc.	$0.886	-3.69%	97,050	N/A	Buy

Frequently Asked Questions

What is After-Hours Trading?

After-hours trading, also called post-market trading, extended-hours trading and post-close session, is the segment of the market that takes place outside of regular trading hours. This often happens after the stock market closes for the day and doesn’t begin again until the next morning. These extended hours can be a great opportunity for investors to get in and out of positions quickly, avoid some of the volatility that comes with traditional trading sessions, and take advantage of opportunities that might not exist during other times. Trading during extended hours is similar to the types of trading you’d do during normal hours, with the exception that volume is often lower. The difference in volume means that the price of a given security may not be as accurate as it would be during normal hours. This can be good for traders who are trying to buy or sell a stock, as it gives them more flexibility.

What is the After-Market Session Timing?

Trading in the after-market takes place from 4:00 pm to 8:00 pm ET.

Who Can Trade After-Market?

Institutional and retail investors can trade after-hours.

Tips for Successful After-Hours Trading

Because volumes are lower, it’s more important than ever to utilize proper risk management. In other words, before you enter any trade, you should have a clear stop-loss in place, and you must follow your trading plan. If you’re new to after-hours trading, it’s important to start small and build your confidence. After all, you don’t want to jump into a trade just because you can do so at an inconvenient time. Instead, you want to use after-hours trading to your advantage and pick times when you know there will be less competition. You can also use after-hours trading to enter short positions. Short selling generally isn’t as common during regular hours, so after-hours trading is a great opportunity to take advantage of this strategy.

What are After-Market Movers?

After-market movers are stocks that have been moved significantly in the after-hours trading session. They are often used as a way to gauge investor sentiment. After-market movers can also be used to identify stocks that have been affected by breaking news or as a way to indicate whether the stock is undergoing any major shifts.

How to Trade the After-Market Movers?

When you’re trading after hours, you’ll need to follow the same basic trading principles that you would during regular hours. In other words, you’ll need to do your research before entering a trade, pick a stock that you believe will rise in value, and use a stop-loss to protect yourself from losses. After-hours trading does give you more flexibility in terms of timing, but you’ll still need to be disciplined and only enter a trade if you feel confident that you’ve done the proper research. Remember that volume is lower during the after-hours session, so moves are often much sharper. When you’re trading stocks after hours, you’re also trading against exchange-traded funds or ETFs. While these funds don’t trade during regular market hours, they often make dramatic moves after markets close. This can create a lot of volatility and is another reason why trading in the after-hours session can be a bit more challenging.

Does after-hours trading affect opening price?

After-market and next-day opening prices can differ significantly. It's possible for a stock to drop a lot in after- hours and then go up when regular trading starts again the next day.

How Do I Find After-Market Movers?

Looking for a stock that will make you rich? Look no further than our After-market Screener! Use our powerful tool to explore stocks with significant price movement or volume after regular trading ends. With just a few clicks, you can quickly and easily find the perfect investment for you. So what are you waiting for? Try our After-Hours Screener today!

After Market Losers - Stocks Telegraph